ABM Therapeutics
PrivateLast Round
Series B
Extension
May 4, 2023
Total Funding Raised
$50M
Company Overview
ABM Therapeutics is a clinical-stage biopharmaceutical company that develops small molecule targeted therapies for the treatment of brain cancer and cancer metastases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials, Precision Medicine
Business Model
B2B
Customer Profile
Revenue Share, Government Contracts
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
ABM Therapeutics Comparables
Compare ABM Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Black Diamond Therapeutics | 78% | |
| Servier | 76% | |
| Suzhou NeuPharma Co., Ltd. | 75% |
ABM Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B Extension | May 4, 2023 | ||||
| Series B | Jan 4, 2022 | ||||
| Series A | Aug 7, 2020 |
ABM Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| HighLight Capital | Series B |
| Photon Fund | Series B |
| Sincere Capital | Series B |
| Jiangsu Honghui Equity Investment Management | Series B |
| Kaitai Capital | Series A |
| 健壹资本 | Series A |
| Baidu Ventures | Series B |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jan 4, 2022
$30M round led by Photon Fund and HighLight Capital
- Aug 7, 2020
$20M round led by 华创资本.
ABM Therapeutics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about ABM Therapeutics's valuation, stock price, and market status.
Is ABM a public or private company?
ABM is a private company.
What is the current stock price of ABM?
ABM is a private company with no public stock price. No recent secondary market data is available.
How much is ABM worth (valuation)?
Valuation information for ABM is not publicly available.
Can I buy ABM stock?
ABM shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was ABM's last funding round?
ABM's most recent funding round was Series B Extension on May 4, 2023.
Who are the main investors in ABM?
Key investors in ABM include HighLight Capital, Photon Fund, 华创资本.
Will ABM IPO soon?
No public IPO plans have been announced for ABM.
How can I track ABM secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor ABM's secondary market activity and sign up for updates.